Dementia – Page 2 – HealthQuill

Shingles can strike anywhere on your body and it most often appears as a single stripe of blisters that wraps around either the left or the right side of the human torso. At times the pain is excruciating.

Herpes Simplex Virus linked to risk of developing Alzheimer’s

HQ Team February 29, 2024: A long-term study of more than a thousand 70 years old people found that those exposed to the.

by HealthQuill
February 19, 2024
0 Comments

Biogen, a US-based biotechnology company, will discontinue the development and commercialisation of its Alzheimer’s treatment and terminate its post-approval study as it failed to rope in a partner to cut costs of obtaining standard regulatory approval.

Drugs Health Pharma

Biogen abandons Alzheimer’s drug Aduhelm to focus on Leqembi

Biogen, a US-based biotechnology company, will discontinue the development and commercialisation of its Alzheimer’s treatment and terminate its post-approval study as it failed.

by HealthQuill
February 1, 2024
0 Comments

Drugs Health Medical Pharma

Metformin may prevent dementia in diabetics, new research suggests  

HQ Team October 27, 2023: Millions of individuals managing diabetes rely on metformin to regulate their blood sugar levels. Recent research highlights the.

by HealthQuill
October 27, 2023
0 Comments

Drugs Health Medical

Taking regular naps can preserve brain health and slow aging, new study reveals

Researchers emphasize the potential benefits of short naps and the importance of maintaining overall brain health in preventing neurodegenerative conditions.

by HealthQuill
June 24, 2023
2 Comments

People suffering from dementia can locate their phones, medicines, glasses, and other objects with the help of companion robots, according to engineers at the University of Waterloo.

Drugs Health Medical Pharma

Robots to help people with dementia find misplaced phones, medicines

HQ Team May 17, 2023: People suffering from dementia can locate their phones, medicines, glasses, and other objects with the help of companion.

by HealthQuill
May 17, 2023
0 Comments

Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.

Drugs Pharma

Eiasi files market authorization for Alzheimer’s drug in Japan

Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.